Autophosphorylation of CaMKK2 Generates Autonomous Activity That is Disrupted by a T85S Mutation Linked to Anxiety and Bipolar Disorder

Overview

Journal Sci Rep

Specialty Science

Date 2015 Sep 24

PMID 26395653

Citations 18

Authors

John W Scott

Elizabeth Park

Ramona M Rodriguiz

Jonathan S Oakhill

Samah M A Issa

Matthew T OBrien

Toby A Dite

Christopher G Langendorf

William C Wetsel

Anthony R Means

Bruce E Kemp

Affiliations

Soon will be listed here.

Abstract

Mutations that reduce expression or give rise to a Thr85Ser (T85S) mutation of Ca(2+)-CaM-dependent protein kinase kinase-2 (CaMKK2) have been implicated in behavioural disorders such as anxiety, bipolar and schizophrenia in humans. Here we report that Thr85 is an autophosphorylation site that endows CaMKK2 with a molecular memory that enables sustained autonomous activation following an initial, transient Ca(2+) signal. Conversely, autophosphorylation of Ser85 in the T85S mutant fails to generate autonomous activity but instead causes a partial loss of CaMKK2 activity. The loss of autonomous activity in the mutant can be rescued by blocking glycogen synthase kinase-3 (GSK3) phosphorylation of CaMKK2 with the anti-mania drug lithium. Furthermore, CaMKK2 null mice representing a loss of function model the human behavioural phenotypes, displaying anxiety and manic-like behavioural disturbances. Our data provide a novel insight into CaMKK2 regulation and its perturbation by a mutation associated with behavioural disorders.

Citing Articles

Loss of calcium/calmodulin-dependent protein kinase kinase 2, transferrin, and transferrin receptor proteins in the temporal cortex of Alzheimer's patients postmortem is associated with abnormal iron homeostasis: implications for patient survival.

Sabbir M Front Cell Dev Biol. 2024; 12:1469751.

PMID: 39669708 PMC: 11634808. DOI: 10.3389/fcell.2024.1469751.

CaMKK2: bridging the gap between Ca2+ signaling and energy-sensing.

McAloon L, Muller A, Nay K, Lu E, Smeuninx B, Means A Essays Biochem. 2024; 68(3):309-320.

PMID: 39268917 PMC: 11576191. DOI: 10.1042/EBC20240011.

CaMKK2 as an emerging treatment target for bipolar disorder.

Kaiser J, Nay K, Horne C, McAloon L, Fuller O, Muller A Mol Psychiatry. 2023; 28(11):4500-4511.

PMID: 37730845 PMC: 10914626. DOI: 10.1038/s41380-023-02260-3.

SGC-CAMKK2-1: A Chemical Probe for CAMKK2.

Wells C, Liang Y, Pulliam T, Lin C, Awad D, Eduful B Cells. 2023; 12(2).

PMID: 36672221 PMC: 9856672. DOI: 10.3390/cells12020287.

Molecular Mechanisms Underlying Ca/Calmodulin-Dependent Protein Kinase Kinase Signal Transduction.

Tokumitsu H, Sakagami H Int J Mol Sci. 2022; 23(19).

PMID: 36232320 PMC: 9570080. DOI: 10.3390/ijms231911025.

References

Lucae S, Salyakina D, Barden N, Harvey M, Gagne B, Labbe M . P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder. Hum Mol Genet. 2006; 15(16):2438-45. DOI: 10.1093/hmg/ddl166. View

Porton B, Rodriguiz R, Phillips L, Gilbert 4th J, Feng J, Greengard P . Mice lacking synapsin III show abnormalities in explicit memory and conditioned fear. Genes Brain Behav. 2010; 9(3):257-68. PMC: 2878384. DOI: 10.1111/j.1601-183X.2009.00555.x. View

Pillai-Nair N, Panicker A, Rodriguiz R, Gilmore K, Demyanenko G, Huang J . Neural cell adhesion molecule-secreting transgenic mice display abnormalities in GABAergic interneurons and alterations in behavior. J Neurosci. 2005; 25(18):4659-71. PMC: 6725026. DOI: 10.1523/JNEUROSCI.0565-05.2005. View

EDELMAN A, Mitchelhill K, Selbert M, Anderson K, Hook S, Stapleton D . Multiple Ca(2+)-calmodulin-dependent protein kinase kinases from rat brain. Purification, regulation by Ca(2+)-calmodulin, and partial amino acid sequence. J Biol Chem. 1996; 271(18):10806-10. DOI: 10.1074/jbc.271.18.10806. View

Curran G, Ravindran A . Lithium for bipolar disorder: a review of the recent literature. Expert Rev Neurother. 2014; 14(9):1079-98. DOI: 10.1586/14737175.2014.947965. View

Barbier E, Wang J . Anti-depressant and anxiolytic like behaviors in PKCI/HINT1 knockout mice associated with elevated plasma corticosterone level. BMC Neurosci. 2009; 10:132. PMC: 2780446. DOI: 10.1186/1471-2202-10-132. View

Kobe B, Kemp B . Active site-directed protein regulation. Nature. 1999; 402(6760):373-6. DOI: 10.1038/46478. View

Woods A, Dickerson K, Heath R, Hong S, Momcilovic M, Johnstone S . Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2005; 2(1):21-33. DOI: 10.1016/j.cmet.2005.06.005. View

Tokumitsu H, Wayman G, Muramatsu M, Soderling T . Calcium/calmodulin-dependent protein kinase kinase: identification of regulatory domains. Biochemistry. 1997; 36(42):12823-7. DOI: 10.1021/bi971348i. View

10.

Tokumitsu H, Iwabu M, Ishikawa Y, Kobayashi R . Differential regulatory mechanism of Ca2+/calmodulin-dependent protein kinase kinase isoforms. Biochemistry. 2001; 40(46):13925-32. DOI: 10.1021/bi010863k. View

11.

Durocher D, Taylor I, Sarbassova D, Haire L, Westcott S, Jackson S . The molecular basis of FHA domain:phosphopeptide binding specificity and implications for phospho-dependent signaling mechanisms. Mol Cell. 2000; 6(5):1169-82. DOI: 10.1016/s1097-2765(00)00114-3. View

12.

Schulman H . The multifunctional Ca2+/calmodulin-dependent protein kinase. Adv Second Messenger Phosphoprotein Res. 1988; 22:39-112. View

13.

Hurley R, Anderson K, Franzone J, Kemp B, Means A, Witters L . The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem. 2005; 280(32):29060-6. DOI: 10.1074/jbc.M503824200. View

14.

Fukui M, Rodriguiz R, Zhou J, Jiang S, Phillips L, Caron M . Vmat2 heterozygous mutant mice display a depressive-like phenotype. J Neurosci. 2007; 27(39):10520-9. PMC: 2855647. DOI: 10.1523/JNEUROSCI.4388-06.2007. View

15.

Peters M, Mizuno K, Ris L, Angelo M, Godaux E, Giese K . Loss of Ca2+/calmodulin kinase kinase beta affects the formation of some, but not all, types of hippocampus-dependent long-term memory. J Neurosci. 2003; 23(30):9752-60. PMC: 6740881. View

16.

Korte S, de Boer S . A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze. Eur J Pharmacol. 2003; 463(1-3):163-75. DOI: 10.1016/s0014-2999(03)01279-2. View

17.

Ogden C, Rich M, Schork N, Paulus M, Geyer M, Lohr J . Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach. Mol Psychiatry. 2004; 9(11):1007-29. DOI: 10.1038/sj.mp.4001547. View

18.

Holt L, Tuch B, Villen J, Johnson A, Gygi S, Morgan D . Global analysis of Cdk1 substrate phosphorylation sites provides insights into evolution. Science. 2009; 325(5948):1682-6. PMC: 2813701. DOI: 10.1126/science.1172867. View

19.

Erickson J, Pereira L, Wang L, Han G, Ferguson A, Dao K . Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation. Nature. 2013; 502(7471):372-6. PMC: 3801227. DOI: 10.1038/nature12537. View

20.

Cao W, Sohail M, Liu G, Koumbadinga G, Lobo V, Xie J . Differential effects of PKA-controlled CaMKK2 variants on neuronal differentiation. RNA Biol. 2011; 8(6):1061-72. PMC: 3256423. DOI: 10.4161/rna.8.6.16691. View